Specifically, while anti‐PD1 therapy alone modestly decreased Ki67 levels, the combination with PCIF1 knockout further suppressed cellular proliferation, implying that the absence of PCIF1 sensitizes tumours to immunotherapy. The gene discussed is PCIF1; the disease is neoplasm.